Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

Gates Foundation Commits $50 Million for Ebola Response

by Global Biodefense Staff
September 10, 2014

The Bill & Melinda Gates Foundation today announced that it will commit $50 million to support the scale up of emergency efforts to contain the Ebola outbreak in West Africa and interrupt transmission of the virus.

The foundation will immediately release flexible funds to United Nations agencies and international organizations involved in the response to enable them and national governments to purchase badly needed supplies and scale up emergency operations in affected countries.

In addition, the foundation will work with public and private sector partners to accelerate the development of therapies, vaccines, and diagnostics that could be effective in treating patients and preventing further transmission of the disease.

“We are working urgently with our partners to identify the most effective ways to help them save lives now and stop transmission of this deadly disease,” said Sue Desmond-Hellmann, CEO of the Gates Foundation. “We also want to accelerate the development of treatments, vaccines and diagnostics that can help end this epidemic and prevent future outbreaks.”

Bill and Melinda Gates FoundationTo date, the Gates Foundation has committed more than $10 million to fight the Ebola outbreak, including $5 million to WHO for emergency operations and R&D assessments and $5 million to the U.S. Fund for UNICEF to support efforts in Liberia, Sierra Leone and Guinea to purchase essential medical supplies, coordinate response activities, and provide at-risk communities with life-saving health information.

An additional $2 million will also be committed immediately to the Centers for Disease Control and Prevention to support incident management, treatment, and health care system strengthening.

In August, Nigeria responded to the current crisis by opening an Emergency Operations Center (EOC) in Lagos, with support from the foundation and the Dangote Foundation. Leveraging expertise and lessons from the national polio program, the EOC has been at the center of an aggressive push by the federal and state governments to contain the spread of the virus, and there is cautious optimism that this prompt action may have helped avert a broader outbreak.

As additional grants are made, the foundation will provide further details on its funding commitments to on-the-ground operations and to research and development for Ebola drugs, vaccines, and diagnostics.

Source: Bill and Melinda Gates Foundation press release

Tags: EbolaLeadership

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations
Medical Countermeasures

Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations

October 25, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC